BCAX
NASDAQ · Biotechnology
Bicara Therapeutics Inc
$8.89
-0.07 (-0.78%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
+63.1% upside
Low Target
$9.75
Average Target
$14.50
High Target
$19.19
Current Price
$8.89
Current
$8.89
$8.89
Target
$14.50
$14.50
$9.75
$14.50 avg
$19.19
Scenario Analysis
Bear Case
$9.75
9.7%
Low target
Base Case
$14.50
+63.1%
Avg target
Bull Case
$19.19
+115.9%
High target
Risk/Reward
12.0x
Highly favorable
Price in Context
52-Week High
$30.99
-71.3% from high
52-Week Low
$8.90
+-0.1% from low
Target vs 52W High
$14.50
-53.2% vs high
Next Earnings Report
Nov 9, 2026 · Before Market Open
2d
until earnings
EPS Est: $-0.85
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +115.6% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -42.4% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.4% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.8% |